Pregnancy

CVS vs Amniocentesis: Timing, Risks, Answers

Save

CVS and amniocentesis both examine fetal chromosomes for a near-certain result. CVS is done earlier, around 10 to 13 weeks, on placental tissue; amniocentesis comes from about 15 weeks and also checks for neural-tube differences. Both carry a small procedure risk, so timing and what you want to know usually drive the choice.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is the difference between CVS and amniocentesis?

Chorionic villus sampling and amniocentesis differ mainly in what they sample and when. CVS removes a tiny piece of placental (chorionic villus) tissue, usually between 10 and 13 weeks, through the cervix or the abdomen 1. Amniocentesis draws a small amount of amniotic fluid, which carries fetal cells, from about 15 weeks onward using a thin needle guided by ultrasound 12. Both examine the full set of fetal chromosomes, so each can confirm or rule out conditions such as trisomy 21 with high accuracy. Amniocentesis also measures a marker linked to neural-tube conditions, which the placental tissue used in CVS cannot assess. For some families, that extra check tips the decision toward amniocentesis.

How do the timing windows affect the choice?

Timing is often the deciding factor between the two tests. CVS delivers answers in the first trimester, around 10 to 13 weeks, which some people prefer for earlier information and more private decision-making 1. Amniocentesis is performed later, from roughly 15 to 20 weeks, and is frequently chosen after a higher-chance screening result or an anatomy-scan finding 2. According to NICE antenatal guidance, diagnostic testing is offered after screening rather than routinely, so the calendar of your pregnancy shapes which test is practical 2. Booking early at your first prenatal appointment leaves room to consider either path. Waiting a few weeks between screening and a diagnostic test is common and reasonable.

What are the real risks of each test?

Both procedures are invasive, so both carry a small added chance of pregnancy loss. Contemporary studies in experienced centers place that added risk far below the roughly 1-in-100 figure quoted in older pamphlets, though estimates vary by center and operator experience, and no single number fits everyone. It helps to hold that next to the background rate: according to ACOG, about 10% of clinically recognized pregnancies end in early loss regardless of any procedure 4. Because that baseline exists, a loss after a test is not always caused by it. Cramping or light spotting can follow either procedure; spotting in early pregnancy has many benign causes, though new heavy bleeding or leaking fluid warrants a call.

Who might lean toward diagnostic testing?

Certain histories make a diagnostic test more likely to be discussed. The baseline chance of a chromosomal condition is lower in the teens and twenties and rises through the late thirties and forties, so counseling about CVS or amniocentesis is more common with older maternal age 3. A prior pregnancy affected by a chromosomal condition, or recurrent pregnancy loss, is another trigger, since genetic evaluation is part of the standard recurrent-loss workup 5. ACOG recommends offering genetic counseling before invasive testing so the decision fits your history 3. Some people reviewing testing after repeated loss arrive already weighing these options. A genetic counselor can translate a family history into concrete choices.

When the CVS-or-amnio decision needs a specialist

A maternal-fetal medicine clinician or genetic counselor is best placed to help you choose between these tests. A counseling visit can lay out the timing, the specific conditions each test detects, the small procedure risk, and what a result would and would not change for your care. Because the two tests suit different weeks and different questions, the right choice is personal rather than universal, and it can shift as new information arrives — a scan finding at 20 weeks, for instance, may move the conversation toward amniocentesis. Bringing your screening results and any earlier scans to the visit makes the discussion sharper. Gale can help you prepare questions for that appointment.

Common questions

Both are highly accurate for chromosomal conditions because they examine fetal chromosomes directly. The main difference is timing and scope: amniocentesis can also assess for neural-tube differences, while CVS offers earlier results.

In experienced hands the added risks are small and broadly similar, and both are much lower than older estimates suggested. A center's and clinician's experience matters, so it is reasonable to ask about local numbers.

NIPT, a cell-free DNA blood screen, is a screening test, not a diagnostic one. It can lower the chance you need an invasive test, but a higher-chance NIPT result is usually confirmed with CVS or amniocentesis.

Preliminary results for common conditions are often available within a few days, while a complete chromosome analysis usually takes one to two weeks. Your clinic can tell you which tests it runs and its typical turnaround.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to call about CVS or amniocentesis

  • Heavy vaginal bleeding, leaking fluid, or a fever after CVS or amniocentesis is a reason to seek same-day clinician or urgent-care review.
  • Severe or worsening abdominal cramping after a procedure is a reason to contact your obstetric clinician promptly.
  • A higher-chance screening or scan result is a reason to arrange genetic counseling before deciding on invasive testing.
  • Distress or anxiety about a result that disrupts sleep or daily life is a reason to reach out to your clinician for support.

If you have heavy bleeding that will not slow, a constant leak of fluid, a high fever, or severe abdominal pain after a procedure, call your obstetric clinician or go to urgent care or labor and delivery; call 911 for fainting or bleeding you cannot control.

This article is general education, not medical advice. The choice between CVS and amniocentesis is best made with an obstetric or maternal-fetal medicine clinician and a genetic counselor who know your history.

References

  1. 1.Office on Women's Health (U.S. HHS) (2025). Prenatal care. Office on Women's Health (womenshealth.gov), U.S. HHS. linkSupports the description of CVS as placental sampling and amniocentesis as amniotic-fluid sampling, their approximate timing windows, and that both are optional diagnostic tests.
  2. 2.National Institute for Health and Care Excellence (2024). Antenatal care (NG201). National Institute for Health and Care Excellence (NICE). linkSupports that diagnostic testing is offered after screening rather than routinely and that amniocentesis is generally performed from around 15 weeks.
  3. 3.American College of Obstetricians and Gynecologists (2019). ACOG Committee Opinion No. 762: Prepregnancy Counseling. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000003013Supports offering genetic counseling before invasive testing and that the chance of a chromosomal condition rises with advanced maternal age.
  4. 4.American College of Obstetricians and Gynecologists (2018). ACOG Practice Bulletin No. 200: Early Pregnancy Loss. Obstetrics & Gynecology. doi:10.1097/AOG.0000000000002899Supports the background figure that about 10% of clinically recognized pregnancies end in early loss independent of any procedure.
  5. 5.Practice Committee of the American Society for Reproductive Medicine (2026). Recurrent pregnancy loss: a committee opinion. Fertility and Sterility. doi:10.1016/j.fertnstert.2026.03.001Supports that genetic evaluation is part of the standard workup for recurrent pregnancy loss, which can factor into decisions about diagnostic testing.

5 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy